CORD-19:2008f024274c53b0de1276f4047a6a641813fd98 / 112454-112685 JSONTXT

{"target":"http://pubannotation.org/docs/sourcedb/CORD-19/sourceid/2008f024274c53b0de1276f4047a6a641813fd98","sourcedb":"CORD-19","sourceid":"2008f024274c53b0de1276f4047a6a641813fd98","text":"Subsequently, incremental doses of 0.025 mg, 0.1 mg, 0.25 mg, 1 mg, 2.5 mg, 7.5 mg, 25 mg, 50 mg, 100 mg, 300 mg, 600 mg, and 1200 mg of amprenavir oral solution were administered via PEG tube at 20 to 30 minute intervals (Table) .","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"T631","span":{"begin":0,"end":231},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T631","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T147","span":{"begin":0,"end":231},"obj":"Sentence"}],"attributes":[{"subj":"T147","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T187","span":{"begin":188,"end":192},"obj":"Body_part"}],"attributes":[{"id":"A187","pred":"uberon_id","subj":"T187","obj":"http://purl.obolibrary.org/obo/UBERON_0000025"},{"subj":"T187","pred":"source","obj":"CORD-19-PD-UBERON"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#93ece3","default":true},{"id":"CORD-19_Custom_license_subset","color":"#ecc993"},{"id":"CORD-19-PD-UBERON","color":"#af93ec"}]}]}}